Translational Research in Neurosurgery Is Improving Lives Now

The Neuroscience Institute at Jersey Shore University Medical Center is Leading Studies for Full Range of Surgical Options

Cutting-edge research being performed at The Neuroscience Institute at Jersey Shore University Medical Center (JSUMC) is translating to better surgical outcomes. JSUMC research teams are investigating a full spectrum of options in neurosurgery, ranging from stem cell research to spinal cord stimulation. Examples include:

• A Pfizer study to evaluate the safety and efficacy of Staphylococcus aureus 4-antigen vaccine (Sa4ag) in adults undergoing elective open posterior spinal fusion procedures with multilevel instrumentation. Staphylococcus aureus is a leading cause of healthcare-associated infections. No preventive vaccine is currently licensed.
• A Zimmer Biomet Avenue T TLIF Cage trial. Avenue T advances posterior lumbar cage technology by incorporating VerteBRIDGE plating, which facilitates simplified cage insertion and zero-profile, intradiscal fixation through a direct, minimally invasive surgical (MIS) approach.
• A study with Medtronic spinal cord stimulation, which uses electrical impulses to relieve chronic pain of the back, arms and legs. It is believed that electrical pulses prevent pain signals from being received by the brain. SCS candidates include people who suffer from neuropathic pain and for whom conservative treatments have failed.
• Work with Nevro’s next-generation spinal cord stimulation system, an evidence-based, nonpharmacologic neuromodulation platform for the treatment of chronic pain. The Nevro system uses biofrequency stimulation, with which patients report greater comfort during stimulation.